Because CEA expression is rare in hepatocellular carcinoma and in malignant mesothelioma, CEA IHC has been suggested as a tool to distinguish mesothelioma from pulmonary adenocarcinoma and hepatocellular carcinoma from liver metastasis [15,16]. Here, CEACAM5 is linked to malignant mesothelioma.